MILLIPORE CORP | Merck KGaA (EMD) | environmental violation | 2010 | EPA | $526,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $15,000 |
MILLIPORE, CIDRA, INC. | Merck KGaA (EMD) | environmental violation | 2000 | EPA | $9,000 |
MODERNA, INC | Moderna Inc. | workplace safety or health violation | 2022 | OSHA | $6,000 |
Momenta Pharmaceuticals Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | campaign finance violation | 2007 | FEC | $9,000 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $36,500,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $2,000,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
Mylan | Viatris | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $96,525,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
Mylan Laboratories et al. | Viatris | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Mylan Laboratories, Inc. | Viatris | consumer protection violation | 2000 | FTC | $100,000,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Mylan N.V. | Viatris | investor protection violation | 2019 | SEC | $30,000,000 |
Mylan N.V. | Viatris | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $264,000,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Mylan Specialty L.P. | Viatris | consumer protection violation | 2013 | OR-AG | $250,000 |
Mylan Specialty, L.P. | Viatris | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
MYLAN TECHNOLOGIES, INC. | Viatris | workplace safety or health violation | 2021 | OSHA | $13,653 |
Neutrogena Corp. | Johnson & Johnson | environmental violation | 2014 | CA-DTSC | $416,248 |
Neutrogena Corporation | Johnson & Johnson | consumer protection violation | 2013 | private lawsuit-federal | $1,800,000 |
Novartis | Novartis | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
Novartis AG | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $126,850,000 |
Novartis Animal Health US, Inc. | Eli Lilly | environmental violation | 2006 | EPA | $6,500 |
NOVARTIS CONSUMER HEALTH INC. | Novartis | workplace safety or health violation | 2013 | OSHA | $6,078 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | environmental violation | 2000 | EPA | $5,000 |
Novartis Corporation | Novartis | employment discrimination | 2010 | private lawsuit-federal | $175,000,000 |
Novartis Corporation and Alcon Laboratories | Novartis | employment discrimination | 2016 | private lawsuit-federal | $8,000,000 |
Novartis Hellas S.A.C.I. et al. | Novartis | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
Novartis Pharmaceuticals | Novartis | kickbacks and bribery | 2015 | USAO | $390,000,000 |
Novartis Pharmaceuticals | Novartis | employment discrimination | 2013 | OFCCP | $51,594 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Novartis Pharmaceuticals | Novartis | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals Corp. | Novartis | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
NOVARTIS PHARMACEUTICALS CORPORATION | Novartis | benefit plan administrator violation | 2006 | EBSA | $10,001 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $13,000 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $5,885 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2016 | private lawsuit-federal | $35,000,000 |
NOVARTIS PRODUCTS | Novartis | environmental violation | 2000 | EPA | $13,200 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Novo Nordisk A/S | Novo Holdings A/S | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | environmental violation | 2000 | EPA | $5,000 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | environmental violation | 2009 | NC-ENV | $36,836 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | environmental violation | 2009 | EPA | $26,797 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | workplace safety or health violation | 2003 | OSHA | $5,610 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | environmental violation | 2016 | EPA | $8,400 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Organon Inc. | Organon & Co. | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Organon USA Inc. | Organon & Co. | drug or medical equipment safety violation | 2018 | private lawsuit-federal | $100,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | consumer protection violation | 2007 | VT-AG | $10,000 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |